GENETIC PREDICTORS OF FCHL IN 4 LARGE PEDIGREES - INFLUENCE OF APO-B LEVEL MAJOR LOCUS PREDICTED GENOTYPE AND LDL SUBCLASS PHENOTYPE

被引:80
作者
JARVIK, GP
BRUNZELL, JD
AUSTIN, MA
KRAUSS, RM
MOTULSKY, AG
WIJSMAN, E
机构
[1] UNIV WASHINGTON,DEPT EPIDEMIOL,DIV ENDOCRINOL & METAB,SEATTLE,WA 98195
[2] UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT GENET,SEATTLE,WA 98195
[3] UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195
[4] UNIV CALIF BERKELEY,LAWRENCE BERKELEY LAB,BERKELEY,CA 94720
来源
ARTERIOSCLEROSIS AND THROMBOSIS | 1994年 / 14卷 / 11期
关键词
APO-B; LDL; GRADIENT GEL PHENOTYPE; FAMILIAL COMBINED HYPERLIPIDEMIA;
D O I
10.1161/01.ATV.14.11.1687
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The genetic basis of familial combined hyperlipidemia (FCHL) has eluded investigators for 20 years, despite the apparent segregation of FCHL as an autosomal dominant disorder affecting 1% to 2% of individuals. Etiologic heterogeneity and additive effects of traits controlled by other genetic loci have been suggested. Two traits have been implicated in FCHL. The first is the predominance of a small, dense low-density lipoprotein (LDL), LDL subclass phenotype B, which segregates as a mendelian trait. The second is a mendelian locus with large effects on apolipoprotein (ape) B levels that is defined by complex segregation analysis (predicted apoB level genotype). This study shows that these factors appear to be separate genetic effects, both of which aid in the prediction of FCHL in four large pedigrees. The results suggest that FCHL may be best predicted by a threshold model in which apoB level genotype and LDL subclass phenotype each act to increase the risk of FCHL. Heterogeneity in the transmission of apoB levels among families is suggested, supporting the etiologic heterogeneity of FCHL. These results emphasize the advantages inherent in the study of large pedigrees when disease heterogeneity is suspected.
引用
收藏
页码:1687 / 1694
页数:8
相关论文
共 61 条
  • [51] ASSOCIATION OF CORONARY ATHEROSCLEROSIS WITH HYPERAPOBETA-LIPOPROTEINEMIA [INCREASED PROTEIN BUT NORMAL CHOLESTEROL LEVELS IN HUMAN-PLASMA LOW-DENSITY (BETA)-LIPOPROTEINS]
    SNIDERMAN, A
    SHAPIRO, S
    MARPOLE, D
    SKINNER, B
    TENG, B
    KWITEROVICH, PO
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (01): : 604 - 608
  • [52] ASSOCIATION OF HYPERAPOBETALIPOPROTEINEMIA WITH ENDOGENOUS HYPERTRIGLYCERIDEMIA AND ATHEROSCLEROSIS
    SNIDERMAN, AD
    WOLFSON, C
    TENG, B
    FRANKLIN, FA
    BACHORIK, PS
    KWITEROVICH, PO
    [J]. ANNALS OF INTERNAL MEDICINE, 1982, 97 (06) : 833 - 839
  • [53] STABLE ISOTOPES SHOW A DIRECT RELATION BETWEEN VLDL APO-B OVERPRODUCTION AND SERUM TRIGLYCERIDE LEVELS AND INDICATE A METABOLICALLY AND BIOCHEMICALLY COHERENT BASIS FOR FAMILIAL COMBINED HYPERLIPIDEMIA
    VENKATESAN, S
    CULLEN, P
    PACY, P
    HALLIDAY, D
    SCOTT, J
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (07): : 1110 - 1118
  • [54] Warnick G R, 1986, Methods Enzymol, V129, P101
  • [55] PLASMA APOLIPOPROTEIN-B AND VLDL-CHOLESTEROL, LDL-CHOLESTEROL, AND HDL-CHOLESTEROL AS RISK-FACTORS IN THE DEVELOPMENT OF CORONARY-ARTERY DISEASE IN MALE-PATIENTS EXAMINED BY ANGIOGRAPHY
    WHAYNE, TF
    ALAUPOVIC, P
    CURRY, MD
    LEE, ET
    ANDERSON, PS
    SCHECHTER, E
    [J]. ATHEROSCLEROSIS, 1981, 39 (03) : 411 - 424
  • [56] WIJSMAN EM, 1992, CIRCULATION, V86, P420
  • [57] POPULATION-BASED FREQUENCY OF DYSLIPIDEMIA SYNDROMES IN CORONARY-PRONE FAMILIES IN UTAH
    WILLIAMS, RR
    HOPKINS, PN
    HUNT, SC
    WU, LL
    HASSTEDT, SJ
    LALOUEL, JM
    ASH, KO
    STULTS, BM
    KUIDA, H
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (03) : 582 - 588
  • [58] COMPLEX SEGREGATION ANALYSIS OF HYPERLIPIDEMIA IN A SEATTLE SAMPLE
    WILLIAMS, WR
    LALOUEL, JM
    [J]. HUMAN HEREDITY, 1982, 32 (01) : 24 - 36
  • [59] FAMILIAL COMBINED HYPERLIPEMIA LINKED TO THE APOLIPOPROTEIN AI-CIII-AIV GENE-CLUSTER ON CHROMOSOME-11Q23-Q24
    WOJCIECHOWSKI, AP
    FARRALL, M
    CULLEN, P
    WILSON, TME
    BAYLISS, JD
    FARREN, B
    GRIFFIN, BA
    CASLAKE, MJ
    PACKARD, CJ
    SHEPHERD, J
    THAKKER, R
    SCOTT, J
    [J]. NATURE, 1991, 349 (6305) : 161 - 164
  • [60] 1980, NIH PUBLICATION, V8, P1527